In last trading session, InMed Pharmaceuticals Inc (NASDAQ:INM) saw 0.34 million shares changing hands with its beta currently measuring 0.69. Company’s recent per share price level of $0.24 trading at $0.0 or 0.30% at ring of the bell on the day assigns it a market valuation of $3.15M. That closing price of INM’s stock is at a discount of -225.0% from its 52-week high price of $0.78 and is indicating a premium of 50.0% from its 52-week low price of $0.12. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.94 million shares which gives us an average trading volume of 6.42 million if we extend that period to 3-months.
For InMed Pharmaceuticals Inc (INM), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 3.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0 in the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
InMed Pharmaceuticals Inc (NASDAQ:INM) trade information
Upright in the green during last session for gaining 0.30%, in the last five days INM remained trading in the red while hitting it’s week-highest on Monday, 11/04/24 when the stock touched $0.24 price level, adding 12.41% to its value on the day. InMed Pharmaceuticals Inc’s shares saw a change of -43.29% in year-to-date performance and have moved -9.44% in past 5-day. InMed Pharmaceuticals Inc (NASDAQ:INM) showed a performance of 12.33% in past 30-days. Number of shares sold short was 40007.0 shares which calculate 0.15 days to cover the short interests.
InMed Pharmaceuticals Inc (INM) estimates and forecasts
This year revenue growth is estimated to rise 47.20% from the last financial year’s standing.
1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 6.77M for the same.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 53.87% during past 5 years.
InMed Pharmaceuticals Inc (NASDAQ:INM)’s Major holders
Insiders are in possession of 0.62% of company’s total shares while institution are holding 8.96 percent of that, with stock having share float percentage of 9.01%. Investors also watch the number of corporate investors in a company very closely, which is 8.96% institutions for InMed Pharmaceuticals Inc that are currently holding shares of the company. SABBY MANAGEMENT, LLC is the top institutional holder at INM for having 0.31 million shares of worth $81571.0. And as of 2024-06-30, it was holding 3.1961 of the company’s outstanding shares.
The second largest institutional holder is VIRTU FINANCIAL LLC, which was holding about 86684.0 shares on 2024-06-30. The number of shares represents firm’s hold over 0.9017 of outstanding shares, having a total worth of $23000.0.
